Please login to the form below

Not currently logged in
Email:
Password:

BI

This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.

Another Alzheimer's bust as Merck & Co stops verubecestat study

Another Alzheimer's bust as Merck & Co stops verubecestat study

Since the start of the year, Boehringer Ingelheim has stopped development of its PDE9a inhibitor BI 4093906, Takeda and Zinfandel abandoned efforts to repurpose diabetes drug pioglitazone for the disease, and

Latest news

More from news
Approximately 4 fully matching, plus 83 partially matching documents found.

Latest Intelligence

  • The ‘Million Hour Challenge’ The ‘Million Hour Challenge’

    Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our

  • Is it time we stopped talking about adherence? Is it time we stopped talking about adherence?

    attractive and valuable bi-product.

  • Deal Watch September 2016 Deal Watch September 2016

    Boehringer Ingelheim granted Amgen worldwide rights to BI 836909, a bispecific T cell engager designed to treat multiple myeloma. ... Under the agreement, Daiichi Sankyo will acquire a licence to Zymeworks' platforms to develop a bi-specific antibody

  • The human perspective The human perspective

    But you can deal with the other three factors. This is where Boehringer has a key strength because there is a very, very strong culture, which is built on our BI

  • Deal Watch April 2016 Deal Watch April 2016

    1, 200. ZymeWorks (US). GSK (UK). License and option. Preclinical bi-specific antibodies based on Azymetric platform for treatment of solid tumours.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest from PMHub

  • Infographic: HIV Market Snapshot

    Therapy Watch HIV patient data is collected bi-monthly from a panel of 150 physicians across the main 5 EU markets and 100 physicians in the US.

  • Box Bear Ltd

    Box Bear Ltd. A boutique agency punching above its weight. Prefered suppliers of GSK, Roche, Shire and BI to name a few, working directly or with partners to deliver animation, video,

  • Frontera

    Gold - Caphosol sales aid - Sales aid. Gold - BI interactive video - Interactive communications.

  • PharmiWeb Solutions Support Cancer Charity

    This inaugural PharmiWeb Solutions “ Bake a Smile” event raised £200.00 on the day, with bi-weekly events already in the diary throughout the rest of 2014, and with Christopher’ s

  • Delivering successful international business intelligence

    He also discusses the approach of configuring a Pharma-specific BI Platform and SaaS solutions as well as touching on hosting choices. .

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics